Product logins

Find logins to all Clarivate products below.


Electrophysiology Mapping and Ablation Devices | Market Insights | US | 2024

The US EP mapping and ablation device market will experience moderate growth through 2032, with trends varying by device segment. The COVID-19 pandemic had a significant impact on some EP ablation procedures in 2020, followed by a period of recovery. Growth in market revenues will be driven by increasing ablation procedure volumes and uptake of premium-priced devices. Innovations in this space will lead to improved outcomes and procedure growth.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for EP mapping and ablation devices in the US from 2019 through 2032.

Related Medtech Insights Reports

Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – United States
The US EP mapping and ablation device market will experience strong growth through 2035, driven by the rapid expansion of AF ablation procedures, particularly PFA devices, and the approval of…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Japan
The Japanese EP mapping and ablation device market will experience moderate growth through 2034, supported by rising cardiac arrhythmia prevalence, broader treatment accessibility, and ongoing…
Report
Electrophysiology Mapping and Ablation Devices | Market Insights | US | 2026
The US EP mapping and ablation device market will experience strong growth through 2034, driven by the rapid expansion of AF ablation procedures and the coinciding uptake of PFA devices,…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Asia Pacific
The Asia Pacific EP mapping and ablation device market will experience strong growth through 2034, driven by rising procedure volumes, new product launches, increasing prevalence of cardiac…